|
|
|
|
Interim Resistance Analysis of Long-Acting Lenacapavir
in Treatment-Naïve People with HIV at 28 Weeks (CALIBRATE)
|
|
|
IDWeek 2021 Virtual Conference, Sep 29-Oct 3, 2021
Laurie VanderVeen, Nicolas Margot, Vidula Naik, Silvia Chang, Ross Martin, Hadas Dvory-Sobol, Martin S. Rhee, Christian Callebaut
Gilead Sciences, Inc., Foster City, CA, USA
|
|
|
|
|
|
|